MINOAS: A Single-arm Translational Phase II Trial of FOLFIRI Plus Aflibercept as First-line Therapy in Unresectable, Metastatic Colorectal Cancer

ConclusionThe activity and safety of first-line FOLFIRI/aflibercept merit further evaluation in randomized studies.Clinicaltrials.gov registration numberNCT02624726.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research